Log In
Print
BCIQ
Print
Print this Print this
 

dofetilide (Tikosyn)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSelective potassium channel blocker
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationFibrillation
Indication DetailsDelay atrial fibrillation (AF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today